NASDAQ:LRMR

Larimar Therapeutics Stock News

etoro logo Buy LRMR
*Your capital is at risk
$4.11
+0.130 (+3.27%)
At Close: Aug 04, 2026
BALA CYNWYD, Pa., May 29, 2020 -- Larimar Therapeutics, Inc. (Nasdaq:LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare.
Several members of the Calgary tech ecosystem have broken ground on a new Innovation Centre.

U.S. firm to assemble phones in Africa

10:56pm, Friday, 09'th Nov 2018
Elias Biryabarema KAMPALA (Reuters) – U.S. firm CTI Africa plans to invest $10 million in Uganda to build a plant to assemble low-end smart mobile phones and manufacture phone components, its…
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE